# Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Ext

Source: https://onco.cc/trials/nct06610734/  
OnCo record `nct06610734` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of adebrelimab in lung cancer, run by Sichuan University, now recruiting.

## Summary

Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) is a phase 2, randomised interventional study registered as NCT06610734 by Sichuan University, with a registry enrolment figure of 202 participants, started 2024-12-23 and due to reach its primary completion in 2026-12. Interventions recorded: Adebrelimab; Chemotherapy; low dose radiotherapy. Conditions listed: Small Cell Lung Cancer Extensive Stage. Primary outcome: overall survival. Lung eligibility wording from the registry: "* Histologically or cytologically confirmed extensive small cell lung cancer (according to the VALG staging system);". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: SKY
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06610734
- Phase: 2
- Setting: Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
- Sponsor: Sichuan University
- Enrolled: 202

## Sources

- ClinicalTrials.gov NCT06610734: https://clinicaltrials.gov/study/NCT06610734

## Connected records

- cancers: [Extensive-stage small-cell lung cancer](https://onco.cc/cancers/extensive-stage-sclc/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06610734.json